U.S. Wound Registry

Quick facts

Phase 2 pipeline

• Cellular and tissue based products · Wound care
  This drug stimulates cellular and tissue repair.
• cellular and tissue based therapy

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• U.S. Wound Registry portfolio CI brief
• U.S. Wound Registry pipeline updates RSS